…
BellRock Brands Inc. develops, markets, and sells cannabis products in the United States, Canada, and internationally. It offers cannabis infused adult-use topicals, confections, edibles, beverages, and concentrates, as well as transdermal patches, tinctures, capsules, lotions, creams, other topicals, vapes, and cosmetic serums. The company also provides branded hemp-infused products for humans and pets. Its brands include Mary's Medicinals, Mary's Nutritionals, Mary's Methods, Mary's Tails, Beezle, Dixie, Synergy, Mindset, Aceso, Therabis, Défoncé, and Rebel Coast. The company was formerly known as Dixie Brands Inc. and changed its name to BellRock Brands Inc. in October 2020. BellRock Brands Inc. is headquartered in Denver, Colorado. BellRock Brands Inc. is a former subsidiary of West 4th Holdings, LLC.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
BellRock Brands Inc is an OTC Pink–listed micro-cap; public filings and investor materials provide limited detail about its operating businesses and financial performance. If management successfully develops consumer brands, secures partnerships or executes acquisitions with transparent reporting, the company could appeal to investors seeking speculative exposure to brand roll-up strategies.
Key investment risks include thin liquidity and volatile trading on the OTC Pink market, likely absence of audited financials, high dilution and financing risk, execution and governance uncertainty common to small, low-reporting issuers, and potential regulatory or compliance issues.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | - | - | - | -0.03M | -21.24M |
| Minority interest | - | - | - | -1.56M | -1.74M |
| Net income | - | - | - | -0.03M | -20.29M |
| Selling general administrative | - | - | - | 0.03M | 18.88M |
| Selling and marketing expenses | - | - | - | 0.01M | - |
| Gross profit | - | - | - | 0.01M | 3.02M |
| Reconciled depreciation | - | - | - | 0.77M | 0.40M |
| Ebit | - | - | - | -0.03M | -20.20M |
| Ebitda | - | - | - | -0.03M | -20.20M |
| Depreciation and amortization | 0.23M | 0.24M | 0.21M | 0.00M | - |
| Operating income | - | - | - | -0.03M | -16.10M |
| Other operating expenses | - | - | - | 0.07M | - |
| Interest expense | - | - | - | 0.00M | 0.00M |
| Net interest income | - | - | - | -2.03M | -0.64M |
| Income tax expense | - | - | - | 0.00M | - |
| Total revenue | - | - | - | 0.03M | 5.79M |
| Total operating expenses | - | - | - | 0.04M | 21.89M |
| Cost of revenue | - | - | - | 0.02M | 2.77M |
| Total other income expense net | - | - | - | -0.00M | -4.50M |
| Net income from continuing ops | - | - | - | -20.44M | -21.24M |
| Net income applicable to common shares | - | - | - | -31.44M | -20.29M |
| Breakdown | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Total assets | 9.73M | 24.90M | 6.35M | 6.00M |
| Intangible assets | 0.42M | 0.68M | 0.61M | 0.78M |
| Other current assets | 0.90M | - | - | - |
| Total liab | 13.86M | 8.96M | 8.56M | 3.97M |
| Total stockholder equity | -2.58M | 17.67M | -1.73M | 2.21M |
| Other current liab | 0.75M | 4.00M | - | - |
| Common stock | 41.56M | 40.23M | 8.96M | 0.00M |
| Retained earnings | -51.45M | -31.31M | -10.73M | -6.69M |
| Other liab | - | 0.24M | 0.50M | 0.39M |
| Other assets | 1.19M | 1.27M | 2.37M | 1.85M |
| Cash | 0.55M | 18.36M | 0.04M | 0.82M |
| Total current liabilities | 13.86M | 8.73M | 7.70M | 2.58M |
| Short term debt | - | 0.78M | 5.81M | 1.46M |
| Short long term debt | 2.60M | 0.78M | 5.81M | 1.46M |
| Other stockholder equity | - | 0.25M | 0.19M | 0.10M |
| Property plant equipment | 0.74M | 0.96M | 0.90M | 1.11M |
| Total current assets | 7.38M | 21.99M | 2.47M | 2.11M |
| Long term investments | - | - | - | 0.14M |
| Net tangible assets | -3.00M | 17.00M | -2.34M | 1.43M |
| Net receivables | 3.16M | 2.27M | 1.86M | 0.73M |
| Long term debt | - | - | 0.30M | 0.90M |
| Inventory | 2.37M | 0.95M | 0.51M | 0.46M |
| Accounts payable | 2.38M | 1.10M | 0.81M | 0.53M |
| Non currrent assets other | - | 2.91M | 3.88M | - |
| Non current assets total | 2.35M | 2.91M | 3.88M | - |
| Capital lease obligations | - | 0.00M | 0.07M | - |
| Breakdown | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Investments | - | -5.59M | -1.58M | -1.17M | -0.14M |
| Change to liabilities | - | 0.00M | 0.15M | 0.28M | 0.08M |
| Total cashflows from investing activities | - | -5.59M | -1.58M | -1.17M | -2.23M |
| Net borrowings | - | 1.82M | -3.11M | 3.29M | 3.48M |
| Total cash from financing activities | - | 2.17M | 23.18M | 3.29M | 3.76M |
| Change to operating activities | - | 2.31M | 3.68M | 0.71M | 0.50M |
| Net income | - | -0.03M | -20.29M | -4.04M | -4.03M |
| Change in cash | - | -17.81M | 18.32M | -0.78M | -0.80M |
| Begin period cash flow | 0.55M | 18.36M | 0.04M | 0.82M | - |
| End period cash flow | 0.55M | 0.55M | 18.36M | 0.04M | 0.82M |
| Total cash from operating activities | - | -14.39M | -3.29M | -2.90M | -2.32M |
| Depreciation | - | 0.77M | 0.40M | 0.47M | 0.44M |
| Other cashflows from investing activities | - | 0.16M | -0.99M | -0.52M | -0.86M |
| Change to inventory | - | -1.42M | -0.44M | -0.05M | 0.17M |
| Change to account receivables | - | -0.71M | -0.39M | -1.17M | 0.77M |
| Other cashflows from financing activities | - | - | 0.05M | 0.05M | 0.05M |
| Change to netincome | - | 6.77M | 13.44M | 0.66M | -0.34M |
| Capital expenditures | 0.00M | 0.35M | 0.59M | 0.05M | 0.34M |
| Change in working capital | - | -1.89M | 4.92M | -0.23M | - |
| Other non cash items | - | 0.03M | 8.80M | 0.24M | - |
| Free cash flow | - | -14.73M | -3.87M | -2.95M | - |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| MKKGY Merck KGaA ADR |
-0.68 2.09% |
31.83 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
163.45 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.38 1.77% |
21.79 | - | 10.96 | 0.01 | 1.20 | 2.94 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
43.05 | - | 10.66 | 0.01 | 1.16 | 2.94 |
BellRock Brands Inc. develops, markets, and sells cannabis products in the United States, Canada, and internationally. It offers cannabis infused adult-use topicals, confections, edibles, beverages, and concentrates, as well as transdermal patches, tinctures, capsules, lotions, creams, other topicals, vapes, and cosmetic serums. The company also provides branded hemp-infused products for humans and pets. Its brands include Mary's Medicinals, Mary's Nutritionals, Mary's Methods, Mary's Tails, Beezle, Dixie, Synergy, Mindset, Aceso, Therabis, Défoncé, and Rebel Coast. The company was formerly known as Dixie Brands Inc. and changed its name to BellRock Brands Inc. in October 2020. BellRock Brands Inc. is headquartered in Denver, Colorado. BellRock Brands Inc. is a former subsidiary of West 4th Holdings, LLC.
| Name | Title | Year Born |
|---|---|---|
| Mr. Brian Jansen | Pres & CEO | NA |
| Mr. Scott M. Ogur CFA | Interim Chief Financial Officer | 1972 |
| Eduardo Provencio | Gen. Counsel, Sr. VP of Legal & Bus. Devel. | NA |
| Mr. Sat Joshi | Chief Strategy Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.